ArticleCellular oncology (Dordrecht, Netherlands)2022

Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy.

Fabrice Viol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.